Oncology Institute (TOI) Short Interest Ratio & Short Volume

Short interest is the volume of Oncology Institute shares that have been sold short but have not yet been covered or closed out. As of December 31st, investors have sold 324,100 shares of TOI short. 0.88% of Oncology Institute's shares are currently sold short. Learn More on Oncology Institute's current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.88% of Oncology Institute's floating shares are currently sold short.

Oncology Institute saw a increase in short interest in the month of December. As of December 31st, there was short interest totaling 324,100 shares, an increase of 86.8% from the previous total of 173,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Oncology Institute currently has issued a total of 75,560,000 shares. Some of Oncology Institute's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncology Institute currently has a public float of 36,800,000 shares.

0.88% of Oncology Institute's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Oncology Institute: P3 Health Partners Inc. (0.89%), Burning Rock Biotech Limited (0.74%), Exagen Inc. (0.90%), Enzo Biochem, Inc. (0.83%), Concord Medical Services Holdings Limited (0.16%), Psychemedics Co. (1.25%), ATI Physical Therapy, Inc. (5.31%), BioRestorative Therapies, Inc. (2.15%), Kindly MD, Inc. (7.06%), Agape ATP Co. (8.27%),

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks.

Short selling TOI is an investing strategy that aims to generate trading profit from Oncology Institute as its price is falling. TOI shares are trading up $0.11 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Oncology Institute occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TOI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOI, twice per month. The most recent reporting period available is December, 31 2024.